- Filed
- May 12, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · May 8, 2025 | 2.83M sh |
| Cash And Equivalents | Q3 2025 · Mar 31, 2025 | $13.86M |
| Cash And Equivalents | Q3 2025 · Jun 30, 2024 | $4.35M |
| Current Liabilities | Q3 2025 · Mar 31, 2025 | $26.51M |
| Current Liabilities | Q3 2025 · Jun 30, 2024 | $15.27M |
| Total Liabilities | Q3 2025 · Mar 31, 2025 | $26.51M |
| Total Liabilities | Q3 2025 · Jun 30, 2024 | $15.27M |
| Current Assets | Q3 2025 · Mar 31, 2025 | $67.36M |
| Current Assets | Q3 2025 · Jun 30, 2024 | $53.24M |
| Total Assets | Q3 2025 · Mar 31, 2025 | $72.84M |
| Total Assets | Q3 2025 · Jun 30, 2024 | $56.54M |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 2.57M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 2.52M sh |
| Dividends Paid | Q3 2025 · Mar 31, 2024 | $1.18M |
| Capex | Q3 2025 · Mar 31, 2024 | $4.5M |
| Operating Cash Flow | Q3 2025 · Mar 31, 2024 | $7.35M |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $39.34M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $38.22M |
| Stockholders Equity | Q3 2025 · Jun 30, 2023 | $35.88M |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | $0.40 |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | $1.56 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | $0.41 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | $1.58 |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $971.22K |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $3.04M |
| Net Income | Q3 2025 · Mar 31, 2024 | $1.03M |
| Net Income | Q3 2025 · Mar 31, 2024 | $3.92M |
| Operating Income | Q3 2025 · Mar 31, 2024 | $1.09M |
| Operating Income | Q3 2025 · Mar 31, 2024 | $4.41M |
| Gross Profit | Q3 2025 · Mar 31, 2024 | $2.06M |
| Gross Profit | Q3 2025 · Mar 31, 2024 | $7.45M |
| Cost Of Revenue | Q3 2025 · Mar 31, 2024 | $6.19M |
| Cost Of Revenue | Q3 2025 · Mar 31, 2024 | $19.67M |
| Revenue | Q3 2025 · Mar 31, 2024 | $8.25M |
| Revenue | Q3 2025 · Mar 31, 2024 | $27.13M |